Therapeutic areas
Malaria in Paediatrics
Phase: III
Sites: 2
Subjects: 350
Benin & Mali
Malaria in Paediatrics
Phase: III-b
Sites: 10
Subjects: 4500
Mozamb, Gambia, Nigeria, Rwanda,
Tuberculosis
Phase: III
Sites: 1
Subjects: 800
Kenya
Meningitis A vaccine
Phase: II, III
Sites: 4
Subjects: 7800
Mali, Ghana, Gambia
HIV Drug (Fixed Dose Combination)
Phase: Il-b
Sites: 4
Subjects: 60
Senegal & Cameroon
Influenza
Phase: III
Sites: 2
Subjects: 600
Senegal
Venous Thrombosis
Phase: IV
Sites: 7
Subjects: 15000
Senegal
Malaria in Children
Phase: IV
Sites: 2
Subjects: 6000
Burkina Faso & Mali
Malaria in Paediatrics
Phase: III-b
Sites: 1
Subjects: 1750
Burkina Faso
Malaria in Pregnancy
Phase: III-b
Sites: 2
Subjects: 2300
Benin & Gabon
Malaria in Pregnancy
Phase: III-b
Sites: 5
Subjects: 5000
Gambia, Ghana, Mali, Burkina Faso
Malaria
Phase: III-b
Sites: 5
Subjects: 3300
Burkina Faso, Guinea, Mali
Malaria
Phase: II
Sites: 1
Subjects: 580
Gabon
Malaria
Phase: III-IV
Sites: 6
Subjects: 6600
Ghana, Burkina Faso, Tanzania,
Malaria
Phase: III
Sites: 4
Subjects: 2100
Mali, Ghana, Nigeria
Cardiovascular
Phase: IV
Sites: 10
Subjects: 330
Nigeria
Severe Malaria in Children
Phase: III-b
Sites: 7
Subjects: 1080
Gabon, Ghana, Gambia, Kenya & Malawi
Malaria (Seasonal Chemoprevention)
Phase: IV
Sites: 2
Subjects: 19200
Burkina Faso & Mali